Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.
Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150
Oxygenated End-Hypothermic Machine Perfusion in Expanded Criteria Donor Kidney Transplant: A Randomized Clinical Trial.
Husen P. et al, (2021), JAMA Surg
Assistive technology and telecare to maintain independent living at home for people with dementia: the ATTILA RCT.
Gathercole R. et al, (2021), Health Technol Assess, 25, 1 - 156
Efficacy of surgical masks or cloth masks in the prevention of viral transmission: Systematic review, meta-analysis, and proposal for future trial.
Nanda A. et al, (2021), J Evid Based Med
The impact of assistive technology on burden and psychological well-being in informal caregivers of people with dementia (ATTILA Study).
Davies A. et al, (2020), Alzheimers Dement (N Y), 6
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2019), Lancet, 393, 1440 - 1452
Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study.
Bryant RJ. et al, (2019), J Urol, 201, 510 - 519
Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT.
Hamdy FC. et al, (2018), Health Technol Assess, 22, 1 - 96
Prostatic capsular incision during radical prostatectomy has important oncological implications: a systematic review and meta-analysis.
Philippou Y. et al, (2018), BJU Int
Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial.
Friedlander M. et al, (2018), Lancet Oncol, 19, 1126 - 1134
THE PART TRIAL - A PHASE III STUDY COMPARING PARTIAL PROSTATE ABLATION VERSUS RADICAL PROSTATECTOMY (PART) IN INTERMEDIATE RISK PROSTATE CANCER - EARLY DATA FROM THE FEASIBILITY STUDY
Leslie T. et al, (2017), JOURNAL OF UROLOGY, 197, E1118 - E1119